Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 195,765 | N/A | N/A | 73,702 |
| Other current assets | 27,718 | 0 | 0 | 15,344 |
| TOTAL | $223,483 | $N/A | $N/A | $89,046 |
| Non-Current Assets | ||||
| PPE Net | 10,093 | N/A | N/A | 10,393 |
| Intangibles | 16 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,655 | 0 | 0 | 1,072 |
| TOTAL | $11,764 | $N/A | $N/A | $11,465 |
| Total Assets | $235,247 | $N/A | $N/A | $97,390 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 5,528 | 0 | 0 | 5,817 |
| Accrued Expenses | 10,292 | N/A | N/A | 6,617 |
| TOTAL | $15,820 | $N/A | $N/A | $12,434 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $15,820 | $N/A | $N/A | $12,434 |
| Shareholders' Equity | ||||
| Common Shares | 137 | N/A | N/A | 0 |
| Retained earnings | -250,935 | N/A | N/A | -119,668 |
| Other shareholders' equity | 11,368 | 0 | 0 | -2,998 |
| TOTAL | $219,427 | $N/A | $N/A | $84,956 |
| Total Liabilities And Equity | $235,247 | $0 | $0 | $97,390 |